Ezekiel Emanuel didn’t talk death-at-75 at this week’s J.P. Morgan conference – he talked money. Namely, the costs associated with health care – what counts as appropriate expenditure, and what’s egregious. Personalized medicine was on his hit list, as he rattled off some of the chinks in the U.S. health care cost structure. The reason, he … Continue reading #JPM15: Ezekiel Emanuel talks health care costs – and why many cancer drugs just aren’t worth it